Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the COVID-19 RNA Vaccine industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
CureVac
ARCoV
Stemirna Therapeutics
Janssen
Zhuhai Livanda Biotechnology Co, Ltd
Pfizer
By Type:
One Shots
Two Shots
By Application:
12-15 YearsOld
Over 16 Years Old
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China COVID-19 RNA Vaccine Market Overview 2018-2029
-
1.1 China COVID-19 RNA Vaccine Industry Development Overview
-
1.2 China COVID-19 RNA Vaccine Industry Development History
-
1.3 China COVID-19 RNA Vaccine Industry Market Size (2018-2029)
-
1.4 China COVID-19 RNA Vaccine Market Analysis by Type from Production Side
-
1.4.1 China COVID-19 RNA Vaccine Production Volume, Production Value and Growth Rate of One Shots (2018-2029)
-
1.4.2 China COVID-19 RNA Vaccine Production Volume, Production Value and Growth Rate of Two Shots (2018-2029)
-
1.5 China COVID-19 RNA Vaccine Market Analysis by Application from Consumption End
-
1.5.1 China COVID-19 RNA Vaccine Sales Volume, Sales Value and Growth Rate of 12-15 YearsOld (2018-2029)
-
1.5.2 China COVID-19 RNA Vaccine Sales Volume, Sales Value and Growth Rate of Over 16 Years Old (2018-2029)
-
1.6 China COVID-19 RNA Vaccine Market Analysis by Region
-
1.6.1 North China COVID-19 RNA Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China COVID-19 RNA Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.3 South China COVID-19 RNA Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.4 East China COVID-19 RNA Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China COVID-19 RNA Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China COVID-19 RNA Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China COVID-19 RNA Vaccine Market Size and Growth Rate from 2018-2029
Chapter 2 China COVID-19 RNA Vaccine Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on COVID-19 RNA Vaccine Market Status and Competition at home and abroad in 2023
-
2.2.2 China COVID-19 RNA Vaccine Market Status and Competition Analysis in 2023
-
2.2.3 China COVID-19 RNA Vaccine Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China COVID-19 RNA Vaccine Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on COVID-19 RNA Vaccine Industry Development
Chapter 3 COVID-19 RNA Vaccine Industry Chain Analysis
-
3.1 COVID-19 RNA Vaccine Industry Chain
-
3.2 COVID-19 RNA Vaccine Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the COVID-19 RNA Vaccine Market
-
3.3 COVID-19 RNA Vaccine Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the COVID-19 RNA Vaccine Market
Chapter 4 China COVID-19 RNA Vaccine Market, by Type
-
4.1 China COVID-19 RNA Vaccine Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China COVID-19 RNA Vaccine Total Production Volume and Growth Rate from Production Side
-
4.5 China COVID-19 RNA Vaccine Production Volume and Growth Rate, by Type
-
4.5.1 China COVID-19 RNA Vaccine Production Volume and Growth Rate of One Shots
-
4.5.2 China COVID-19 RNA Vaccine Production Volume and Growth Rate of Two Shots
Chapter 5 China COVID-19 RNA Vaccine Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China COVID-19 RNA Vaccine Total Market Size and Growth Rate from Consumption End
-
5.5 China COVID-19 RNA Vaccine Market Size and Growth Rate, by Application
-
5.5.1 China COVID-19 RNA Vaccine Market Size and Growth Rate of 12-15 YearsOld
-
5.5.2 China COVID-19 RNA Vaccine Market Size and Growth Rate of Over 16 Years Old
Chapter 6 China COVID-19 RNA Vaccine Market, by Region
-
6.1 China COVID-19 RNA Vaccine Production Volume and Production Value, by Region
-
6.2 China COVID-19 RNA Vaccine Sales Volume and Sales Value, by Region
Chapter 7 North China COVID-19 RNA Vaccine Market Analysis
-
7.1 North China COVID-19 RNA Vaccine Market, by Type
-
7.2 North China COVID-19 RNA Vaccine Market, by Application
Chapter 8 Central China COVID-19 RNA Vaccine Market Analysis
-
8.1 Central China COVID-19 RNA Vaccine Market, by Type
-
8.2 Central China COVID-19 RNA Vaccine Market, by Application
Chapter 9 South China COVID-19 RNA Vaccine Market Analysis
-
9.1 South China COVID-19 RNA Vaccine Market, by Type
-
9.2 South China COVID-19 RNA Vaccine Market, by Application
Chapter 10 East China COVID-19 RNA Vaccine Market Analysis
-
10.1 East China COVID-19 RNA Vaccine Market, by Type
-
10.2 East China COVID-19 RNA Vaccine Market, by Application
Chapter 11 Northeast China COVID-19 RNA Vaccine Market Analysis
-
11.1 Northeast China COVID-19 RNA Vaccine Market, by Type
-
11.2 Northeast China COVID-19 RNA Vaccine Market, by Application
Chapter 12 Southwest China COVID-19 RNA Vaccine Market Analysis
-
12.1 Southwest China COVID-19 RNA Vaccine Market, by Type
-
12.2 Southwest China COVID-19 RNA Vaccine Market, by Application
Chapter 13 Northwest China COVID-19 RNA Vaccine Market Analysis
-
13.1 Northwest China COVID-19 RNA Vaccine Market, by Type
-
13.2 Northwest China COVID-19 RNA Vaccine Market, by Application
Chapter 14 Company Profiles
-
14.1 CureVac
-
14.1.1 CureVac Company Profile
-
14.1.2 CureVac COVID-19 RNA Vaccine Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 ARCoV
-
14.2.1 ARCoV Company Profile
-
14.2.2 ARCoV COVID-19 RNA Vaccine Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Stemirna Therapeutics
-
14.3.1 Stemirna Therapeutics Company Profile
-
14.3.2 Stemirna Therapeutics COVID-19 RNA Vaccine Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Janssen
-
14.4.1 Janssen Company Profile
-
14.4.2 Janssen COVID-19 RNA Vaccine Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Zhuhai Livanda Biotechnology Co, Ltd
-
14.5.1 Zhuhai Livanda Biotechnology Co, Ltd Company Profile
-
14.5.2 Zhuhai Livanda Biotechnology Co, Ltd COVID-19 RNA Vaccine Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Pfizer
-
14.6.1 Pfizer Company Profile
-
14.6.2 Pfizer COVID-19 RNA Vaccine Market Performance
-
14.6.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 COVID-19 RNA Vaccine Industry Research Conclusions
-
15.2 COVID-19 RNA Vaccine Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China COVID-19 RNA Vaccine Industry Market Size (2018-2029)
-
Figure China COVID-19 RNA Vaccine Production Volume, Production Value and Growth Rate of One Shots (2018-2029)
-
Figure China COVID-19 RNA Vaccine Production Volume, Production Value and Growth Rate of Two Shots (2018-2029)
-
Figure China COVID-19 RNA Vaccine Sales Volume, Sales Value and Growth Rate of 12-15 YearsOld (2018-2029)
-
Figure China COVID-19 RNA Vaccine Sales Volume, Sales Value and Growth Rate of Over 16 Years Old (2018-2029)
-
Figure North China COVID-19 RNA Vaccine Market Size and Growth Rate from 2018-2029
-
Figure Central China COVID-19 RNA Vaccine Market Size and Growth Rate from 2018-2029
-
Figure South China COVID-19 RNA Vaccine Market Size and Growth Rate from 2018-2029
-
Figure East China COVID-19 RNA Vaccine Market Size and Growth Rate from 2018-2029
-
Figure Northeast China COVID-19 RNA Vaccine Market Size and Growth Rate from 2018-2029
-
Figure Southwest China COVID-19 RNA Vaccine Market Size and Growth Rate from 2018-2029
-
Figure Northwest China COVID-19 RNA Vaccine Market Size and Growth Rate from 2018-2029
-
Figure COVID-19 RNA Vaccine Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China COVID-19 RNA Vaccine Market Share by Type in 2018
-
Figure China COVID-19 RNA Vaccine Market Share by Type in 2023
-
Figure China COVID-19 RNA Vaccine Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China COVID-19 RNA Vaccine Production Volume and Growth Rate of One Shots (2018-2023)
-
Figure China COVID-19 RNA Vaccine Production Volume and Growth Rate of Two Shots (2018-2023)
-
Figure China COVID-19 RNA Vaccine Market Share by Application in 2018
-
Figure China COVID-19 RNA Vaccine Market Share by Application in 2023
-
Figure China COVID-19 RNA Vaccine Total Market Size and Growth Rate from Consumption End
-
Figure China COVID-19 RNA Vaccine Market Size and Growth Rate of 12-15 YearsOld (2018-2023)
-
Figure China COVID-19 RNA Vaccine Market Size and Growth Rate of Over 16 Years Old (2018-2023)
-
Table China COVID-19 RNA Vaccine Production Volume by Region (2018-2023)
-
Table China COVID-19 RNA Vaccine Production Volume Share by Region (2018-2023)
-
Figure China COVID-19 RNA Vaccine Production Volume Share by Region (2018-2023)
-
Table China COVID-19 RNA Vaccine Production Value by Region (2018-2023)
-
Table China COVID-19 RNA Vaccine Production Value Share by Region (2018-2023)
-
Figure China COVID-19 RNA Vaccine Production Value Share by Region (2018-2023)
-
Table China COVID-19 RNA Vaccine Sales Volume by Region (2018-2023)
-
Table China COVID-19 RNA Vaccine Sales Volume Share by Region (2018-2023)
-
Figure China COVID-19 RNA Vaccine Sales Volume Share by Region (2018-2023)
-
Table China COVID-19 RNA Vaccine Sales Value by Region (2018-2023)
-
Table China COVID-19 RNA Vaccine Sales Value Share by Region (2018-2023)
-
Figure China COVID-19 RNA Vaccine Sales Value Share by Region (2018-2023)
-
Table North China COVID-19 RNA Vaccine Production Volume by Type (2018-2023)
-
Table North China COVID-19 RNA Vaccine Production Volume Share by Type (2018-2023)
-
Figure North China COVID-19 RNA Vaccine Production Volume Share by Type (2018-2023)
-
Table North China COVID-19 RNA Vaccine Sales Volume by Application (2018-2023)
-
Table North China COVID-19 RNA Vaccine Sales Volume Share by Application (2018-2023)
-
Figure North China COVID-19 RNA Vaccine Sales Volume Share by Application (2018-2023)
-
Table Central China COVID-19 RNA Vaccine Production Volume by Type (2018-2023)
-
Table Central China COVID-19 RNA Vaccine Production Volume Share by Type (2018-2023)
-
Figure Central China COVID-19 RNA Vaccine Production Volume Share by Type (2018-2023)
-
Table Central China COVID-19 RNA Vaccine Sales Volume by Application (2018-2023)
-
Table Central China COVID-19 RNA Vaccine Sales Volume Share by Application (2018-2023)
-
Figure Central China COVID-19 RNA Vaccine Sales Volume Share by Application (2018-2023)
-
Table South China COVID-19 RNA Vaccine Production Volume by Type (2018-2023)
-
Table South China COVID-19 RNA Vaccine Production Volume Share by Type (2018-2023)
-
Figure South China COVID-19 RNA Vaccine Production Volume Share by Type (2018-2023)
-
Table South China COVID-19 RNA Vaccine Sales Volume by Application (2018-2023)
-
Table South China COVID-19 RNA Vaccine Sales Volume Share by Application (2018-2023)
-
Figure South China COVID-19 RNA Vaccine Sales Volume Share by Application (2018-2023)
-
Table East China COVID-19 RNA Vaccine Production Volume by Type (2018-2023)
-
Table East China COVID-19 RNA Vaccine Production Volume Share by Type (2018-2023)
-
Figure East China COVID-19 RNA Vaccine Production Volume Share by Type (2018-2023)
-
Table East China COVID-19 RNA Vaccine Sales Volume by Application (2018-2023)
-
Table East China COVID-19 RNA Vaccine Sales Volume Share by Application (2018-2023)
-
Figure East China COVID-19 RNA Vaccine Sales Volume Share by Application (2018-2023)
-
Table Northeast China COVID-19 RNA Vaccine Production Volume by Type (2018-2023)
-
Table Northeast China COVID-19 RNA Vaccine Production Volume Share by Type (2018-2023)
-
Figure Northeast China COVID-19 RNA Vaccine Production Volume Share by Type (2018-2023)
-
Table Northeast China COVID-19 RNA Vaccine Sales Volume by Application (2018-2023)
-
Table Northeast China COVID-19 RNA Vaccine Sales Volume Share by Application (2018-2023)
-
Figure Northeast China COVID-19 RNA Vaccine Sales Volume Share by Application (2018-2023)
-
Table Southwest China COVID-19 RNA Vaccine Production Volume by Type (2018-2023)
-
Table Southwest China COVID-19 RNA Vaccine Production Volume Share by Type (2018-2023)
-
Figure Southwest China COVID-19 RNA Vaccine Production Volume Share by Type (2018-2023)
-
Table Southwest China COVID-19 RNA Vaccine Sales Volume by Application (2018-2023)
-
Table Southwest China COVID-19 RNA Vaccine Sales Volume Share by Application (2018-2023)
-
Figure Southwest China COVID-19 RNA Vaccine Sales Volume Share by Application (2018-2023)
-
Table Northwest China COVID-19 RNA Vaccine Production Volume by Type (2018-2023)
-
Table Northwest China COVID-19 RNA Vaccine Production Volume Share by Type (2018-2023)
-
Figure Northwest China COVID-19 RNA Vaccine Production Volume Share by Type (2018-2023)
-
Table Northwest China COVID-19 RNA Vaccine Sales Volume by Application (2018-2023)
-
Table Northwest China COVID-19 RNA Vaccine Sales Volume Share by Application (2018-2023)
-
Figure Northwest China COVID-19 RNA Vaccine Sales Volume Share by Application (2018-2023)
-
Table CureVac Company Profile
-
Table CureVac COVID-19 RNA Vaccine Revenue, Price and Gross (2018-2023)
-
Table ARCoV Company Profile
-
Table ARCoV COVID-19 RNA Vaccine Revenue, Price and Gross (2018-2023)
-
Table Stemirna Therapeutics Company Profile
-
Table Stemirna Therapeutics COVID-19 RNA Vaccine Revenue, Price and Gross (2018-2023)
-
Table Janssen Company Profile
-
Table Janssen COVID-19 RNA Vaccine Revenue, Price and Gross (2018-2023)
-
Table Zhuhai Livanda Biotechnology Co, Ltd Company Profile
-
Table Zhuhai Livanda Biotechnology Co, Ltd COVID-19 RNA Vaccine Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer COVID-19 RNA Vaccine Revenue, Price and Gross (2018-2023)
-
